|
1
|
Thiele H, Desch S, Piek JJ, Stepinska J,
Oldroyd K, Serpytis P, Montalescot G, Noc M, Huber K, Fuernau G, et
al: Multivessel versus culprit lesion only percutaneous
revascularization plus potential staged revascularization in
patients with acute myocardial infarction complicated by
cardiogenic shock: Design and rationale of CULPRIT-SHOCK trial. Am
Heart J. 172:160–169. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cerisano G, Buonamici P, Valenti R, Moschi
G, Taddeucci E, Giurlani L, Migliorini A, Vergara R, Parodi G,
Sciagrà R, et al: Effects of a timely therapy with doxycycline on
the left ventricular remodeling according to the pre-procedural
TIMI flow grade in patients with ST-elevation acute myocardial
infarction. Basic Res Cardiol. 109:4122014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wang HL, Xing SY, Dong PS, Han YH, Zhu JH,
Lai LH and Zhao JF: Safety and efficacy of intracoronary tirofiban
administration in patients with serious thrombus burden and
ST-elevation myocardial infarction undergoing percutaneous coronary
intervention. Eur Rev Med Pharmacol Sci. 18:3690–3695.
2014.PubMed/NCBI
|
|
4
|
Dohi T, Maehara A, Brener SJ, Généreux P,
Gershlick AH, Mehran R, Gibson CM, Mintz GS and Stone GW: Utility
of peak creatine kinase-MB measurements in predicting myocardial
infarct size, left ventricular dysfunction, and outcome after first
anterior wall acute myocardial infarction (from the INFUSE-AMI
trial). Am J Cardiol. 115:563–570. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Matsumoto S, Sakata Y, Suna S, Nakatani D,
Usami M, Hara M, Kitamura T, Hamasaki T, Nanto S, Kawahara Y and
Komuro I: Circulating p53-responsive microRNAs are predictive
indicators of heart failure after acute myocardial infarction. Circ
Res. 113:322–326. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Biasucci LM and Cardillo MT: MicroRNA and
myocardial infarction: A mystery turning into glory? J Am Coll
Cardiol. 62:999–1001. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Huang W, Tian SS, Hang PZ, Sun C, Guo J
and Du ZM: Combination of microRNA-21 and microRNA-146a attenuates
cardiac dysfunction and apoptosis during acute myocardial
infarction in mice. Mol Ther Nucleic Acids. 5:e2962016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Eryilmaz U, Akgüllü Ç, Beşer N, Yıldız Ö,
Kurt Ömürlü İ and Bozdoğan B: Circulating microRNAs in patients
with ST-elevation myocardial infarction. Anatol J Cardiol.
16:392–396. 2016.PubMed/NCBI
|
|
9
|
Marfella R, Sasso FC, Siniscalchi M,
Paolisso P, Rizzo MR, Ferraro F, Stabile E, Sorropago G, Calabrò P,
Carbonara O, et al: Peri-procedural tight glycemic control during
early percutaneous coronary intervention is associated with a lower
rate of in-stent restenosis in patients with acute ST-elevation
myocardial infarction. J Clin Endocrinol Metab. 97:2862–2871. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ketha H and Singh RJ: Clinical assays for
quantitation of insulin-like-growth-factor-1 (IGF1). Methods.
81:93–98. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jackson R, Tilokee EL, Latham N, Mount S,
Rafatian G, Strydhorst J, Ye B, Boodhwani M, Chan V, Ruel M, et al:
Paracrine engineering of human cardiac stem cells with insulin-like
growth factor 1 enhances myocardial repair. J Am Heart Assoc.
4:e0021042015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Nelson DM, Hashizume R, Yoshizumi T,
Blakney AK, Ma Z and Wagner WR: Intramyocardial injection of a
synthetic hydrogel with delivery of bFGF and IGF1 in a rat model of
ischemic cardiomyopathy. Biomacromolecules. 15:1–11. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ge RT, Mo LH, Wu R, Liu JQ, Zhang HP, Liu
Z, Liu Z and Yang PC: Insulin-like growth factor-1 endues monocytes
with immune suppressive ability to inhibit inflammation in the
intestine. Sci Rep. 5:77352015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Krieger F, Elflein N, Saenger S, Wirthgen
E, Rak K, Frantz S, Hoeflich A, Toyka KV, Metzger F and Jablonka S:
Polyethylene glycol-coupled IGF1 delays motor function defects in a
mouse model of spinal muscular atrophy with respiratory distress
type 1. Brain. 137:1374–1393. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Saddic LA, Chang TW, Sigurdsson MI,
Heydarpour M, Raby BA, Shernan SK, Aranki SF, Body SC and
Muehlschlegel JD: Integrated microRNA and mRNA responses to acute
human left ventricular ischemia. Physiol Genomics. 47:455–462.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gao LR, Chen Y, Zhang NK, Yang XL, Liu HL,
Wang ZG, Yan XY, Wang Y, Zhu ZM, Li TC, et al: Intracoronary
infusion of Wharton's jelly-derived mesenchymal stem cells in acute
myocardial infarction: Double-blind, randomized controlled trial.
BMC Med. 13:1622015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tan NS, Goodman SG, Cantor WJ, Tan MK, Yan
RT, Bagnall AJ, Mehta SR, Fitchett D, Strauss BH and Yan AT:
TRANSFER-AMI Investigators: Comparison of the efficacy of
pharmacoinvasive management for ST-segment elevation myocardial
infarction in smokers versus non-smokers (from the Trial of Routine
Angioplasty and Stenting After Fibrinolysis to Enhance Reperfusion
in Acute Myocardial Infarction). Am J Cardiol. 114:955–961. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Minamisawa M, Izawa A, Motoki H, Kashima
Y, Hioki H, Abe N, Miura T, Ebisawa S, Miyashita Y, Koyama J and
Ikeda U: Prognostic significance of neuroadrenergic dysfunction for
cardiovascular events in patients with acute myocardial infarction.
Circ J. 79:2238–2245. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Weinreuter M, Kreusser MM, Beckendorf J,
Schreiter FC, Leuschner F, Lehmann LH, Hofmann KP, Rostosky JS,
Diemert N, Xu C, et al: CaM Kinase II mediates maladaptive
post-infarct remodeling and pro-inflammatory chemoattractant
signaling but not acute myocardial ischemia/reperfusion injury.
EMBO Mol Med. 6:1231–1245. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Rios E, Mancio J, Rodrigues-Pereira P,
Magalhães D and Bartosch C: Large myocardial infarction with
myocardium calcium deposits associated with reperfusion injury.
Cardiovasc Pathol. 23:379–380. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Rayner K, Dimmeler S, Calin GA, Thum T,
Raizman JE and Diamandis EP: Novel biomarkers for acute myocardial
infarction: Is microRNA the new kid on the block? Clin Chem.
60:812–817. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ma LN, Li LD, Li SC, Hao XM, Zhang JY, He
P and Li YK: Allicin improves the cardiac function by protecting
against apoptosis in rat model of myocardial infarction. Chin J
Integr Med. 23:589–597. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ueda S, Yamagishi S, Matsui T, Jinnouchi Y
and Imaizumi T: Administration of pigment epithelium-derived factor
inhibits left ventricular remodeling and improves cardiac function
in rats with acute myocardial infarction. Am J Pathol. 178:591–598.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang Y, Zhang H, Chai F, Liu X and Berk M:
The effects of escitalopram on myocardial apoptosis and the
expression of Bax and Bcl-2 during myocardial ischemia/reperfusion
in a model of rats with depression. BMC Psychiatry. 14:3492014.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Malick M, Gilbert K, Barry M, Godbout R
and Rousseau G: Desvenlafaxine reduces apoptosis in amygdala after
myocardial infarction. Brain Res Bull. 109:158–163. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Huang Y, Harrison MR, Osorio A, Kim J,
Baugh A, Duan C, Sucov HM and Lien CL: Igf signaling is required
for cardiomyocyte proliferation during zebrafish heart development
and regeneration. PLoS One. 8:e672662013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sengupta A, Kalinichenko VV and Yutzey KE:
FoxO1 and FoxM1 transcription factors have antagonistic functions
in neonatal cardiomyocyte cell-cycle withdrawal and IGF1 gene
regulation. Circ Res. 112:267–277. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Anversa P, Reiss K, Kajstura J, Cheng W,
Li P, Sonnenblick EH and Olivetti G: Myocardial infarction and the
myocyte IGF1 autocrine system. Eur Heart J. 16 Suppl N:S37–S45.
1995. View Article : Google Scholar
|
|
30
|
Andreassen M, Raymond I, Kistorp C,
Hildebrandt P, Faber J and Kristensen LØ: IGF1 as predictor of all
cause mortality and cardiovascular disease in an elderly
population. Eur J Endocrinol. 160:25–31. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lai CH, Ho TJ, Kuo WW, Day CH, Pai PY,
Chung LC, Liao PH, Lin FH, Wu ET and Huang CY: Exercise training
enhanced SIRT1 longevity signaling replaces the IGF1 survival
pathway to attenuate aging-induced rat heart apoptosis. Age
(Dordr). 36:97062014. View Article : Google Scholar : PubMed/NCBI
|
